These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 32384406)

  • 61. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
    Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adding Narrow-Band Imaging to Chromoendoscopy for the Evaluation of Tumor Response to Neoadjuvant Therapy in Rectal Cancer.
    Ishioka M; Chino A; Ide D; Saito S; Igarashi M; Nagasaki T; Akiyoshi T; Nagayama S; Fukunaga Y; Ueno M; Kawachi H; Yamamoto N; Fujisaki J; Konishi T
    Dis Colon Rectum; 2021 Jan; 64(1):53-59. PubMed ID: 32639283
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adverse Oncologic Outcomes of Adenocarcinoma of the Anal Canal in Patients With Crohn's Disease.
    Yasuhara M; Beppu N; Uchino M; Ikeuchi H; Matsuda I; Hirota S; Ikeda M; Tomita N
    Dis Colon Rectum; 2021 Apr; 64(4):409-419. PubMed ID: 33394780
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
    Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery.
    Eckberg SE; Dahlberg MJA; der Hagopian OS; Farahnak P; Sandblom GK; Nordenvall CAM; Everhov ÅH
    Dis Colon Rectum; 2021 Feb; 64(2):171-180. PubMed ID: 33315716
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Value of the Tumor-Stroma Ratio and Structural Heterogeneity Measured by a Novel Semiautomatic Image Analysis Technique for Predicting Survival in Patients With Colon Cancer.
    Inoue H; Kudou M; Shiozaki A; Kosuga T; Shimizu H; Kiuchi J; Arita T; Konishi H; Komatsu S; Kuriu Y; Morinaga Y; Konishi E; Otsuji E
    Dis Colon Rectum; 2023 Nov; 66(11):1449-1461. PubMed ID: 36649165
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correlation Between the Distance to Mesorectal Fascia and Prognosis of cT3 Rectal Cancer: Results of a Multicenter Study From China.
    Zhang XY; Li XT; Shi YJ; Lu QY; Cao W; Zhang HM; Wang L; Zhu HT; Yu T; Guan Z; Sun RJ; Zhu HB; Wu AW; Sun YS
    Dis Colon Rectum; 2022 Mar; 65(3):322-332. PubMed ID: 34459446
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Compliance With Preoperative Elements of the American Society of Colon and Rectal Surgeons Rectal Cancer Surgery Checklist Improves Pathologic and Postoperative Outcomes.
    Garfinkle R; Vasilevsky CA; Ghitulescu G; Morin N; Faria J; Boutros M
    Dis Colon Rectum; 2020 Jan; 63(1):30-38. PubMed ID: 31804269
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.
    Williams H; Thompson HM; Lin ST; Verheij FS; Omer DM; Qin LX; Garcia-Aguilar J;
    Dis Colon Rectum; 2024 Mar; 67(3):369-376. PubMed ID: 38039292
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years.
    Ghabra S; Desale S; Sugarbaker PH
    Dis Colon Rectum; 2023 Oct; 66(10):1329-1338. PubMed ID: 36856661
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
    Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
    Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Prognostic Impact of Preoperative Osteopenia in Patients With Colorectal Cancer.
    Kato H; Seishima R; Mizuno S; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
    Dis Colon Rectum; 2023 Dec; 66(12):e1225-e1233. PubMed ID: 37699124
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
    Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
    Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 Expression.
    Duggan WP; Kisakol B; O'Connell E; Matveeva A; O'Grady T; McDonough E; Lindner AU; McNamara D; Longley D; Ginty F; Burke JP; Prehn JHM
    Dis Colon Rectum; 2023 Jul; 66(7):914-922. PubMed ID: 36525395
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Age and Lymph Node Positivity in Patients With Colon and Rectal Cancer in the US Military Health System.
    Alexander MS; Lin J; Shriver CD; McGlynn KA; Zhu K
    Dis Colon Rectum; 2020 Mar; 63(3):346-356. PubMed ID: 31842166
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
    Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of Clinicopathological Characteristics of Appendiceal Tumors in Japan: A Multicenter Collaborative Retrospective Clinical Study- A Japanese Nationwide Survey.
    Matsui S; Murata K; Fukunaga Y; Takeda T; Fujii M; Yamaguchi T; Kagawa Y; Mizushima T; Ohno Y; Yao T; Doki Y; Sugihara K
    Dis Colon Rectum; 2020 Oct; 63(10):1403-1410. PubMed ID: 32969883
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of the Collagen Signature in the Tumor Microenvironment With Recurrence and Survival of Patients With T4N0M0 Colon Cancer.
    Chen W; Dong S; Liu X; Wang G; Xu S; Lei S; Zhuo S; Yan J
    Dis Colon Rectum; 2021 May; 64(5):563-575. PubMed ID: 33538520
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
    Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
    Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.